RP BIOLOGICS LTD - Accounts

Registered Number: 15289555

England and Wales

Unaudited Financial Statements

for the period ended 31 March 2026

for

RP BIOLOGICS LTD

RP BIOLOGICS LTD

Statement of Financial Position

As at 31 March 2026

	£	2026 £	£	2025 £
Fixed assets		437		872
Current assets	14,371		9,465
Creditors: amount falling due within one year	(10,535)		(10,079)
Net current assets/(liabilities)		3,836		(614)
Total assets less current liabilities		4,273		258
Net assets/(liabilities)		4,273		258


Capital and reserves		4,273		258

For the period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:

---------------------------------------------

Renata Pankiewicz
Director

Date approved: 05 May 2026

RP BIOLOGICS LTD

Notes to the Accounts

For the period ended 31 Mar 2026

Statutory Information

Rp Biologics Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 15289555, registered office 36 Kirby Road, Waterbeach, Cambridge, CB25 9LX, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the period was 1 (2025: 1).

3.	Director Advances Credits Note At 31 March 2026 the director owed £637.41 to RP BIOLOGICS LTD. The loan is interest- free, unsecured and has no set repayment terms.